You can buy or sell Fibrocell and other stocks, options, ETFs, and crypto commission-free!
Fibrocell Science Inc. Common Stock, also called Fibrocell, is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Read More Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on December 28, 1995 and is headquartered in Exton, PA.
52 Week High
52 Week Low
Associated PressMar 20
Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. - Company to provide update on Type B meeting with FDA on Phase 3 clinical trial design for FCX-007 gene therapy candidate for recessive dystrophic epidermolysis bullosa (RDEB) - - Company to highlight updated data from ongoi...
Simply Wall StMar 11
Is Fibrocell Science, Inc. (NASDAQ:FCSC) A Volatile Stock?
If you’re interested in Fibrocell Science, Inc. (NASDAQ:FCSC), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second type is the broader market volatility, which you c...
-$0.62 per share
Available Mar 27, Pre-Market